Novo Nordisk suffers another loss in efforts to extend key Ozempic patent in Brazil

To Read The Full Story

Continue reading your article with a Membership

Counsel

Novo Nordisk was represented by Dannemann Siemsen’s Bernardo Marinho Fontes Alexandre, Rodrigo de Assis Torres, Juliana Nogueira de Sá Cardoso Coelho, Rafael Quaresma Bastos, Deborah Anália Lima Campos, Paulo Henrique de Paiva Santos, and Tatiana Neves de Assumpção, as well as BJMR’s Gustavo Prieto Moisés, ASJ Advogados’s Maria Zuleika de Oliveira Rocha, João Paulo Moraes Almeida, Carlos Da Costa e SIlva Filho, and FCDG’s Davi Machado Evangelista, Marcelo Roberto Ferro, and Leonardo Marins; and Mateus Rocha Tomaz of Bermudes Advogados.